01 2Curia New York, Inc.
02 1MAEDA INC
01 1VORINOSTAT
02 1Vorinostat Coarse
03 1Vorinostat Fine
01 2U.S.A
02 1Blank
NDC Package Code : 65392-3102
Start Marketing Date : 2006-10-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (55kg/55kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 65392-3101
Start Marketing Date : 2006-10-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (55kg/55kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 86184-423
Start Marketing Date : 2023-08-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Vorinostat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vorinostat, including repackagers and relabelers. The FDA regulates Vorinostat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vorinostat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vorinostat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vorinostat supplier is an individual or a company that provides Vorinostat active pharmaceutical ingredient (API) or Vorinostat finished formulations upon request. The Vorinostat suppliers may include Vorinostat API manufacturers, exporters, distributors and traders.
click here to find a list of Vorinostat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vorinostat as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vorinostat API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vorinostat as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vorinostat and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vorinostat NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vorinostat suppliers with NDC on PharmaCompass.
LOOKING FOR A SUPPLIER?
